Cochlear Baha

Baha sound processor
Type Cochlear Baha 3 sound processor (BP100)
Manufacturer Cochlear Limited
Country of origin Sweden. Purchased by Australian company Cochlear in 2005.
Introduced 1977
Website www.cochlear.com

The Baha is a bone conduction hearing system designed, developed and marketed by Cochlear. When Cochlear bought the Swedish company Entific Medical Systems in 2005, the acronym BAHA was trademarked into Baha, since it is not considered a hearing aid by insurance companies.

The Baha is a semi-implantable percutaneous bone conduction hearing device coupled to the skull by an osseointegrated titanium fixture.[1] The system transfers sound to the inner ear through the bone, thereby bypassing problems in the outer or middle ear. Candidates with a conductive, mixed or single-sided sensorineural hearing loss can therefore benefit from bone conduction hearing solutions.

Since dr Anders Tjellström at Sahlgrenska University Hospital in Gothenburg, Sweden, implanted and fitted the first patient with a Baha in 1977, an increasing number of clinics around the world offer implantable bone conduction hearing solutions as a method of treatment. More adults and children are implanted with a Baha every year, from only 3 in 1977 to over 75,000 users today.[2]

Contents

History

Professor Per-Ingvar Brånemark famously discovered osseointegration in the 1950s which allows titanium implants to fuse with human bone. The discovery led to wide use in dental implants. In the mid 1970s Brånemark, together with his ENT colleague Dr Anders Tjellström, glued an Oticon bone vibrator to a snap coupling fitted to a dental implant and then connected it to an audiometer. The patient reported a very high, clear sound. It was obvious that the sound propagated very well through the bones of the maxilla to the inner ear. This became the starting point for the future development of the hearing device Baha together with the titanium implant.[3]

How Baha works

The Baha System reroutes the sound by sending it through the bone, bypassing the outer and middle ears, directly to the functioning inner ear through bone conduction.

Surgery

The process involved in getting a Baha is relatively simple. Surgery generally takes place in an outpatient setting, causing minimum disruption and stress. Normal activity can be resumed within a few days.

Implantation

The procedure is minor and often performed in an outpatient facility with local or general anaesthesia. The surgeon prepares a small area behind the ear, 50–55 mm from the ear canal and line with the top of the pinna, removing a small amount of hair follicles. The area (approximately 24 mm in diameter) closest to the abutment will remain hair free. A Baha titanium implant with an abutment will be inserted in the centre of this area. The implant is 4 mm long and the abutment is 6 mm. When surgery is complete, the top of the abutment is on the same level as the skin.

Healing

After surgery, a dressing which should be changed regularly is required. The stitched are usually removed within 10–14 days. Some numbness in the area around the abutment can occur. Most likely this condition is temporary. Once the dressing is removed it is important to keep the abutment area clean using a supplied cleaning brush. Good hygiene is critical to maintaining normal usage of Baha sound processors. Users who are unable to clean the skin themselves need help from family members or caregivers.

Osseointegration

With the improved size and surface of the Baha 3 Implant (BI300) it is no longer necessary to wait 12 weeks after surgery for fitting. Studies show that osseointegration now occurs as early as three weeks after surgery.

Fitting

The Baha sound processor will be fitted at a hearing clinic. A hearing care professional adjusts the sound settings to suit the patient's personal requirements. The sound processor is designed to snap onto the abutment by holding it at a slight angle and put into place with a click. To take it off, place one finger under the device and gently tilt off.

Candidates and indications

In cases where there are complications with the middle ear, or when one ear does not function, sound can't reach its destination. Hearing care professionals agree that for these types of problems Baha is a more effective solution than air conduction devices.[5]

Candidates for Baha include patients with outer or middle ear problems (conductive hearing loss), middle and inner ear problems (mixed hearing loss) and no hearing at all in one ear (Single-Sided Deafness). In the first two cases, Baha reroutes the sound via the skull to the cochlea. In SSD, Baha transfers the signal directly to the hearing ear, making it possible to perceive sounds from both sides.

There are several other medical indications where Baha can be treated for hearing loss:

References

  1. ^ Dun, Catharina A. J.; Faber, Hubert T.; de Wolf, Maarten J. F.; Cremers, Cor W. R. J.; Hol, Myrthe K. S. (2011). "An Overview of Different Systems: The Bone-Anchored Hearing Aid". In Kompis, Martin; Caversaccio, Marco-Domenico. Implantable Bone Conduction Hearing Aids. Advances in Oto-Rhino-Laryngology. 71. pp. 22–31. doi:10.1159/000323577. ISBN 978-3-8055-9700-5. 
  2. ^ Gompelmann, Daniela; Eberhardt, Ralf; Heuβel, Claus-Peter; Hoffmann, Hans; Dienemann, Hendrik; Schuhmann, Maren; Böckler, Dittmar; Schnabel, Philipp A. et al. (2011). "Lung Sequestration: A Rare Cause for Pulmonary Symptoms in Adulthood". Respiration 82 (5): 445–50. doi:10.1159/000323562. 
  3. ^ Brånemark, PI; Hansson, BO; Adell, R; Breine, U; Lindström, J; Hallén, O; Ohman, A (1977). "Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period". Scandinavian journal of plastic and reconstructive surgery. Supplementum 16: 1–132. PMID 356184. 
  4. ^ http://www.cochlear.com/uk/cochlear-baha-3
  5. ^ Snik, AF; Mylanus, EA; Proops, DW; Wolfaardt, JF; Hodgetts, WE; Somers, T; Niparko, JK; Wazen, JJ et al. (2005). "Consensus statements on the BAHA system: Where do we stand at present?". The Annals of otology, rhinology & laryngology. Supplement 195: 2–12. PMID 16619473. 

External links